Yahoo Web Search

Search results

    • Analyst Report: argenx SE

      Morningstar Research via Yahoo Finance· 10 hours ago

      Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was approved in the U.S. in December 2021 as a treatment ...

    • Hannover Rueck SE's Dividend Analysis

      Hannover Rueck SE's Dividend Analysis

      GuruFocus.com via Yahoo Finance· 4 days ago

      Hannover Rueck SE (HVRRY) recently announced a dividend of $1.07 per share, payable on 2024-05-20, with the ex-dividend date set for 2024-05-07. As...